News & Updates
News
Aduhelm Saga Continues as Lawmakers Plan to Investigate Approval, Pricing
The U.S. Food and Drug Administration (FDA) approved Biogen’s Aduhelm (aducanumab) for Alzheimer’s disease on June 7, but the fallout continues.
If a Medicine Is Too Expensive, Should a Hospital Make Its Own?
When Marleen Kemper was a child, she watched two of her primary-school classmates get ill. One had a brain tumour, and the other contracted an infection in his gut. Both of them died. Kemper was around ten at the time, and knew that she didn’t want to see another friend perish. She told her parents she wanted to do something that would prevent others dying. She wanted to be a doctor.
Senate must pass bill to enable the government to negotiate lower prescription drug prices
Every time I hear a constituent struggling to afford next month’s medications, wondering whether they’ll have to choose between paying for a lifesaving prescription and paying rent, the same question — the same frustration — rushes through my mind...
CVS cut 72 drugs with ‘hyperinflated’ prices from its formulary last year
Posaconazole, an antifungal medication, is priced at $4,500 for a 30-day supply—while an alternative, fluconazole, costs less than $14.
Is a bad drug for Alzheimer’s better than no drug?
On June 7, the Food and Drug Administration approved the sale of a new drug, aducanumab, (brand name Aduhelm) to treat Alzheimer’s disease. That might seem like good news for people suffering from this debilitating affliction and their families. But the agency’s failure to follow normal approval procedures raises serious concerns.
How a single new Alzheimer’s drug could blow up the federal budget
A new medicine could cost taxpayers hundreds of billions of dollars. Will Washington crack down on drug prices in response?
Eleven generic versions of an HIV drug rush onto the market… and list prices go up
Inside the relationship between drugmakers, insurers, pharmacy benefit managers, the drug counter and you.
Suggested Reasons for Price of Prescription Drugs in America
Theories Among Americans on Why They Pay So Much For Drugs...
With antitrust emerging as key concern on Capitol Hill, drug pricing comes to the fore
Congress is beginning to take notice as corporations become increasingly dominant in one or more marketplaces.
Biden health official ‘taking a look’ at Trump drug pricing proposal
A key Biden administration health official said Thursday that she is "taking a look" at one of former President Trump's proposals to lower drug prices, but did not commit to pursuing the plan.